Featured Video

Subcutaneous Immunoglobulin: Feasibility and Safety in Neuromuscular Diseases
Zaeem A. Siddiqi, MD, PhD
University of Alberta, Edmonton, Alberta, Canada
7:20 MIN
  • CIDP
  • GBS
  • MMN

Learn how subcutaneous immunoglobulin provides the additional benefit of flexibility of home infusion in patients with neuromuscular disease.

Our Experts

Zaeem A. Siddiqi, MD, PhD
University of Alberta, Edmonton, Alberta, Canada
Zaeem A. Siddiqi, MD, PhD
Zaeem A. Siddiqi, MD, PhD
University of Alberta, Edmonton, Alberta, Canada
  • CIDP
  • GBS
  • MMN
Dr. Zaeem Siddiqi, MD, PhD is an Associate Professor of Medicine (Neurology) at the University of Alberta and Director of the neuromuscular program.
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
Hans D. Katzberg, MD, MSc, FRCP(C)
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
  • MMN
Dr. Hans Katzberg is a neuromuscular specialist and clinical investigator at the University Health Network / Toronto General Hospital and has been on faculty at the University of Toronto as Assistant Professor of Neurology.
Karissa Gable, MD
Duke University Medical Center in Durham, North Carolina
Karissa Gable, MD
Karissa Gable, MD
Duke University Medical Center in Durham, North Carolina
  • CIDP
Dr. Karissa Gable is a Neuromuscular specialist at Duke University Medical Center in Durham, North Carolina.
Peter Donofrio, MD
Vanderbilt University Medical Center, Nashville, TN, USA
Peter Donofrio, MD
Peter Donofrio, MD
Vanderbilt University Medical Center, Nashville, TN, USA
  • CIDP
  • GBS
Peter D. Donofrio, M.D. is a Professor of Neurology at Vanderbilt University Medical Center. He is a graduate of The Ohio State University School of Medicine and pursued a residency in neurology and a neuromuscular fellowship at the University of Michigan.
Back to Top